GREAT LAB
  • Home
  • GReAT Research
  • Carole Yauk
  • GReAT people
  • GReAT Collaborators
  • Equity, Diversity and Inclusion
  • Opportunities
  • Publications
  • Contact
  • In the News


​Meet the GReATs!

Picture

Eunnara Cho
PhD candidate

​Eunnara's project involves collaborating with researchers across industry, government and academia to investigate how the application of newer in vitro assays in genetic toxicology can be guided by Adverse Outcome Pathways (https://aopwiki.org/). The work integrates high-throughput DNA damage assays with genomic technologies, such as TempO-seq for gene expression analysis and duplex sequencing for mutation detection.
Picture

Anne-Marie Fortin
MSc candidate

​​Anne-Marie's research focus is quantitative toxicogenomics. She is working with the TGx-DDI biomarker, a transcriptomic multigene biomarker that identifies DNA-damaging chemical agents in human cells. The project aims to determine genetic toxicity point‐of‐departure (PoD) metrics for TGx-DDI, and to investigate the incorporation of the TGx-DDI biomarker into Health Canada's GeneTox21 testing program.

​Co-supervisor: Paul White, Health Canada and adjunct uOttawa
​
Picture

David Eickmeyer, MSc
GReAT lab senior technician

​​Dave's background is in paleolimnology and organic environmental contaminant isolation and quantification, having focused mainly on PAHs, PCBs, and OC pesticides. He is looking forward to helping get the GReAT lab up and running and doing what he can to bring some order to chaos.

​
Picture

Elizabeth Huliganga
MSc candidate

​Elizabeth is working in predictive toxicology, developing approaches that we hope someday will reduce or eliminate the need for conventional toxicology tests like those done in animals. She is doing experiments to collect empirical evidence to build Adverse Outcome Pathways (AOPs: https://aopwiki.org/). Specifically, her work involves determining the quantitative relationships between increases in oxidative stress, DNA damage, mutations and chromosomal aberrations.
​
Co-supervisor: Francesco Marchetti, Health Canada and  adjunct at Carleton
Picture
Tatiana Kozbenko
MSc candidate
​​Tatiana is our rocket scientist! She is building space-flight relevant AOPs (adverse outcome pathways). Specifically, she is collecting and analyzing data to support the link ionizing radiation in space and resulting cardiovascular disease, ocular disorders, bone loss and cognitive effects. Tatiana is also passionate about science communication and has completed the illustrations for our GReAT website!

Co-Supervisor: Vinita Chauhan, Health Canada
​
Picture
Geronimo Parodi-Matteo
​PhD Student​
Geronimo is conducting research to determine the toxicity of plasticizers that are used to replace Bisphenol A (BPA), a widely studied endocrine disrupting chemical. Canada was the first country to take regulatory action on BPA. Many new chemicals have since emerged as replacements to BPA and Geronimo is using high-throughput transcriptomics to study the estrogenic activity and potency of these replacements. He's also exploring how these chemicals interact in mixtures to cause toxicity and inform regulatory decision-making. His work is helping to catalyze the modernization of human health risk assessment.
​

Co-supervisor: Ella Atlas, Health Canada and adjunct at uOttawa
Picture
Annette Dodge
​MSc candidate
​​Annette's research focuses on the application of new in vivo assays in genetic toxicology. Specifically, she is working on applying Duplex Sequencing™ as a novel method for the analysis of mutation induction and spectra in tissues exposed to toxic substances. This work aims to investigate if Duplex Sequencing could serve as a new standard for in vivo mutagenicity testing that obviates the need for transgenic organisms.
 
Co-supervisor: Francesco Marchetti, Health Canada and adjunct at Carleton
Picture
David Schuster
PhD Student
David’s project works towards validation of a novel error-corrected sequencing method called Duplex Sequencing (DS). He is comparing mutation frequencies and spectra measured by DS to conventional mutagenicity endpoints. His project involves many international collaborators to potentially establish DS as the new gold standard for in vivo mutagenicity testing.

Co-supervisor: Francesco Marchetti, Health Canada, and adjunct at Carleton
Picture
Jonatan Axelsson
Visiting scientist
​Jonatan is a physician who is visiting the GReAT lab from Sweden. His research focuses on the role of environmental and life-style related factors that may mediate germ cell mutation frequencies and spectra in males as possible explanations behind diseases in offspring. He is studying mutation using DS in both mice and humans to explore this possibility.
Picture
Hyojin Lee
Post-doctoral fellow
​Hyojin's research in the GReAT lab explores the underlying molecular mechanisms of toxicity and potency of per- and poly-fluorinated substances (PFAS) both individually and when present in mixtures. She will be determining benchmark dose (BMD) /point-of-departure (POD) of PFASs using the zebrafish model and transcriptomics and performing class-based hazard assessments of PFAS mixture. 
 
Supervisors: Hyojin has three supervisors for this complex multi-disciplinary project. Carole Yauk and Jan Mennigen (uOttawa), and Jason O’Brien from Environment and Climate Change Canada

Gone on to other great things
Picture
Anthony Reardon, post-doctoral fellow
Anthony was doing research to understand the toxicological effects of per- and poly-fluoroalkyl substances (PFAS), often referred to as 'forever chemicals'. With over 4,000 in the environment, he used transcriptomic profiling technologies to understand the dose-response behaviours of untested PFAS on their own and in mixtures.

​Co-supervisor: Ella Atlas, Health Canada and adjunct uOttawa

Anthony is now a regulatory scientist in the Existing Substances and Risk Assessment Bureau at Health Canada. He's putting the newest approaches in genomics and in vitro tests into action in regulatory decision making to protect human health.
​

Picture
 
Kundai Mufara, volunteer
 Kundai was a volunteer helping us to  build Adverse Outcome Pathways linking chemically induced DNA damage to  downstream effects like chromosome breaks and mutations. She's now a
science content writer for an environmental software company, combining her love of science, writing and communication.
http://kuecreates.com/professional-portfolio/

Powered by Create your own unique website with customizable templates.
  • Home
  • GReAT Research
  • Carole Yauk
  • GReAT people
  • GReAT Collaborators
  • Equity, Diversity and Inclusion
  • Opportunities
  • Publications
  • Contact
  • In the News